SPORANOX 10 mg/ml, oral solution bottle, 150 ml
Active ingredients: Itraconazole
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPORANOX 10 mg/mL, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) de 150 ml en verre brun avec fermeture de sécurité enfant avec gobelet doseur gradué polypropylène
- Marketing authorisation holder
- JANSSEN CILAG
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69998156CIP73450206CIP133400934502064Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ITRACONAZOLEsolution | 1,00 g · 100 mL de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.